Fig. 6.
Serum GH concentration (ng/mL) and serum PRL concentration (ng/mL) in T1, T2 and C groups vaccinated with pEGS/2SS-tPA, pEGS/2SS and pEGFP-N1 at 8 week after immunization. *P<0.05 and **P<0.01.
Serum GH concentration (ng/mL) and serum PRL concentration (ng/mL) in T1, T2 and C groups vaccinated with pEGS/2SS-tPA, pEGS/2SS and pEGFP-N1 at 8 week after immunization. *P<0.05 and **P<0.01.